z-logo
open-access-imgOpen Access
Detection of gyrA Mutation Among Clinical Isolates of Campylobacter jejuni Isolated in Egypt by MAMA-PCR
Author(s) -
Mayar Maged Said,
Hanan El-Mohamady,
Fawkia M. El-Beih,
David Rockabrand,
Tharwat F. Ismail,
Marshall R. Monteville,
Salwa F. Ahmed,
John D. Klena,
Mohamed Salama
Publication year - 2010
Publication title -
the journal of infection in developing countries
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.322
H-Index - 49
eISSN - 2036-6590
pISSN - 1972-2680
DOI - 10.3855/jidc.963
Subject(s) - campylobacter jejuni , campylobacter , microbiology and biotechnology , ciprofloxacin , nalidixic acid , biology , campylobacter coli , dna gyrase , quinolone , antibiotics , gene , genetics , bacteria , escherichia coli
Campylobacter spp are the major cause of enteritis in humans and more than 90% of reported infections are caused by Campylobacter jejuni. Fluoroquinolones such as ciprofloxacin are the antibiotics of choice for treatment. An increase in the frequency of ciprofloxacin-resistant Campylobacter has been reported globally due to a single base mutation (C-257 to T) in codon 86 of the quinolone resistance determining region (QRDR) of the gyrA gene altering the amino acid sequence from threonine at position 86 to isoleucine (Thr-86 to Ile).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom